sr141716 has been researched along with Nervous System Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedogni, G; Chavez-Tapia, NC; Crocè, LS; Masutti, F; Tellez-Avila, FI; Tiribelli, C | 1 |
1 review(s) available for sr141716 and Nervous System Disorders
| Article | Year |
|---|---|
Systematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatology.
Topics: Cannabinoid Receptor Antagonists; Fatty Liver; Humans; Mental Disorders; Nervous System Diseases; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Treatment Outcome | 2009 |